LMX 5 delivers maximum-strength topical anesthesia through 5% lidocaine formulation, the highest concentration available for non-prescription use, providing rapid local anesthetic efficacy for anorectal pathology management. The advanced delivery system facilitates deep tissue penetration, enabling lidocaine distribution to affected mucous membranes and submucosal structures for comprehensive pain modulation. The fast-acting mechanism produces onset of anesthesia within minutes of application, effectively suppressing nociceptive signaling associated with hemorrhoids, anal fissures, and post-procedural discomfort. The cream base provides optimal viscosity for targeted application without systemic absorption, minimizing adverse effects while maintaining localized therapeutic concentration. The 1.7 oz (48g) container provides adequate volume for extended symptomatic management across multiple applications. The formulation addresses acute anorectal pain syndromes and facilitates patient comfort during minor dermatological procedures requiring local anesthesia. This professional-grade topical anesthetic represents an evidence-based therapeutic option for individuals experiencing anorectal discomfort seeking rapid, effective pain relief without oral medication administration or invasive interventions.
